Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics

Go back to Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
HAEMONETICS CORPORATION (NYSE: HAE) Delayed: 118.51 +2.35 (2.02%)
Previous Close $116.16    52 Week High $39.41 
Open $115.50    52 Week Low $25.98 
Day High $119.20    P/E 166.92 
Day Low $115.49    EPS $0.71 
Volume 777,372       

(NASDAQ: OBIO) Delayed: 5.59 +0.12 (2.19%)
Previous Close $5.47    52 Week High $ 
Open $5.46    52 Week Low $ 
Day High $5.66    P/E N/A 
Day Low $5.39    EPS $ 
Volume 262,009